The FDA has approved Attruby, a new oral treatment that helps reduce heart-related deaths and hospital visits among adults ...
A popular thyroid medication taken by 23 million Americans may be associated with bone loss, a startling new study finds.
More than 200,000 prescriptions for copies of Novo Nordisk's weight-loss drug Wegovy are getting filled by U.S. patients each ...
Merck said on Monday its drug, Winrevair, helped significantly reduce the risk of death in patients with a rare condition ...
We hope you have a smashing day and conquer the world. And do keep in touch. … Martin Makary, President-elect Trump’s pick to ...
The Food and Drug Administration approved on Friday a new medicine from BridgeBio for patients with a progressive heart ...
The approval of Attruby for transthyretin amyloidosis with cardiomyopathy begins a battle for control of a lucrative market ...
In the ENBALV study, it was inconclusive whether edoxaban is a better treatment than warfarin for patients with early ...
As many as 136 million adult Americans may be eligible for Ozempic, researchers estimate. According to a study published ...
CVKD READ THE FULL CVKD RESEARCH REPORT Business Update Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) is a biopharmaceutical company developing tecarfarin, a late-stage novel oral and reversible ...
Hosted on MSN5d
Generic medicines tend to be cheaper than brand names. Here's how much you could saveAny Australian who has filled a prescription at the chemist will have been asked if they want a branded product or the generic version. And with consumers looking to cut costs wherever they can, ...
Cadrenal aims to develop a better VKA blood thinner for these warfarin-dependent patients. Cadrenal Therapeutics, Inc. is a biopharmaceutical company focused on developing tecarfarin, a clinical-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback